Análisis de una propuesta terapéutica para un paciente adulto con diabetes mellitus ii asociada a un síndrome metabólico.

Abstract

Type II diabetes mellitus (DM2) is a chronic disease characterized by high blood glucose levels, which in the long term can develop metabolic disorders. The etiology of metabolic syndrome is unknown, however, bibliographical research highlights the important interaction of genetic, metabolic, environmental factors, toxic habits such as smoking and diet are responsible for altering this disease. For this reason, a non-pharmacological and pharmacological treatment is proposed as a general objective in an adult patient with Diabetes Mellitus II metabolic syndrome, through a bibliographic review to contribute to the patient's quality of life. Methodology: In the present investigation, an analytical-descriptive methodology was used based on the bibliographic review of magazines and scientific articles, to improve the clinical picture of the patient. Results: In the pharmacological treatment, Metformin 850 mg and Glipizide 5mg are replaced by Vildagliptin/Metformin 50 mg/850 mg; and acetylsalicylic acid 100mg for Rivaroxaban 20mg. In addition, the consumption of simvastatin is suspended because the patient reflects normal levels of total cholesterol and the administration of orlistat 60 to 120 mg three times a day is recommended to lower his BMI. Conclusion: It was possible to make a therapeutic proposal which suggests complying with a Mediterranean diet and aerobic exercises at a moderate intensity in such a way that the patient can reduce their BMI and blood glucose levels. Finally, family support is recommended for greater adherence to treatment.